GLOW (70mg)

GLOW – 70 mg

For In Vitro Research Use Only
Not for Human or Veterinary Application

Product Overview

GLOW is a lyophilized co-formulation research blend consisting of three distinct bioactive peptide compounds: TB-500 (10 mg), BPC-157 (10 mg), and GHK-Cu (50 mg), co-lyophilized into a single unit for use in multi-target in vitro research applications. Each component targets distinct molecular pathways — actin cytoskeletal dynamics (TB-500), gastrointestinal mucosal and angiogenic signaling (BPC-157), and copper-mediated extracellular matrix and antioxidant biology (GHK-Cu). GLOW is intended for use as a combinatorial research tool in studies examining the interactions and combined effects of these three peptide classes within a unified experimental system.

Specifications

• Quantity: 70 mg total (TB-500: 10 mg | BPC-157: 10 mg | GHK-Cu: 50 mg)

• Form: Lyophilized Powder (co-formulated blend)

• Components: TB-500 (Ac-LKKTETQ) | BPC-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) | GHK-Cu (Gly-His-Lys copper complex)

• Purity: ≥99.4% per component (third-party verified)

• Storage: -20°C long-term; 4°C short-term (use within 4 weeks of reconstitution); protect from light

Research Context

TB-500 contributes G-actin sequestration activity via the LKKTET actin-binding motif, studied in contexts of cytoskeletal remodeling, ILK pathway activation, and VEGF-associated angiogenesis in fibroblast and endothelial cell assays. BPC-157 is researched for its effects on VEGFR2 expression, nitric oxide synthase pathway modulation, and FAK-paxillin signaling associated with cell migration and extracellular matrix interaction. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring plasma tripeptide studied for its capacity to modulate matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression, antioxidant gene upregulation via Nrf2 pathway engagement, and collagen and glycosaminoglycan synthesis in dermal fibroblast models. The co-lyophilized format enables researchers to investigate potential additive or interactive effects of these three distinct peptide mechanisms within a single experimental preparation.

Intended Use

This compound is intended strictly for in vitro laboratory research by qualified professionals.
It is not approved for:

• Human use

• Veterinary use

• Food, drug, diagnostic, or cosmetic applications

Regulatory Disclaimer

• This compound has not been evaluated by the U.S. Food and Drug Administration (FDA).

• It is not intended to diagnose, treat, cure, or prevent any disease.

• All handling and use must comply with applicable institutional, local, state, and federal regulations.

Terms of Sale

By purchasing from Axis Peptide Labs, the buyer confirms that they are a qualified researcher, laboratory, or institution and acknowledge that the product is for research use only.

• All sales are final.

• The purchaser assumes full responsibility for compliant handling, storage, and use.

• Resale for human consumption is strictly prohibited.